Furin targeted drug delivery for treatment of rhabdomyosarcoma in a mouse model.
Furin targeted drug delivery for treatment of rhabdomyosarcoma in a mouse model.
复制标题
DOI:
10.1371/journal.pone.0010445
复制
发表时间:
2010-05-03
期刊:
影响因子:
3.7
通讯作者:
Bernasconi M
中科院分区:
文献类型:
--
作者:
Hajdin K;D'Alessandro V;Niggli FK;Schäfer BW;Bernasconi M
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children. Improvement of treatment efficacy and decreased side effects through tumor-targeted drug delivery would be desirable. By panning with a phage-displayed cyclic random peptide library we selected a peptide with strong affinity for RMS in vitro and in vivo. The peptide minimal binding motif Arg-X-(Arg/Lys)(Arg/Lys) identified by alanine-scan, suggested the target receptor to be a proprotein convertase (PC). Expression profiling of all PCs in RMS biopsies and cell lines revealed consistent high expression levels for the membrane-bound furin and PC7. Direct binding of RMS-P3 peptide to furin was demonstrated by affinity chromatography and supported by activity and colocalization studies. Treatment of RMS in mice with doxorubicin coupled to the targeting peptide resulted in a two-fold increase in therapeutic efficacy compared to doxorubicin treatment alone. Our findings indicate surface-furin binding as novel mechanism for therapeutic cell penetration which needs to be further investigated. Furthermore, this work demonstrates that specific targeting of membrane-bound furin in tumors is possible for and suggests that RMS and other tumors might benefit from proprotein convertases targeted drug delivery.
登录
查看更多内容
影响因子:
11.2
作者:
Fogal V;Zhang L;Krajewski S;Ruoslahti E
通讯作者:
Ruoslahti E
影响因子:
4.8
作者:
Khatib, AM;Siegfried, G;Seidah, NG
通讯作者:
Seidah, NG
影响因子:
6
作者:
Bassi, DE;Mahloogi, H;Klein-Szanto, A
通讯作者:
Klein-Szanto, A
影响因子:
5.8
作者:
Breitfeld, PP;Meyer, WH
通讯作者:
Meyer, WH
影响因子:
4.1
作者:
Bergeron, E;Basak, A;Seidah, NG
通讯作者:
Seidah, NG